FRT vs GCTK · rev $1.28B vs P/E 0.1, $4.1M cap
FRT (FRT) versus GlucoTrack Inc (GCTK) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
GCTK does not have a complete income-statement cache yet.
FRT currently screens at market cap $0. GCTK currently screens at market cap $4.1M and trailing P/E 0.1.
Not investment advice. Open the FRT and GCTK stock pages for the full models.
Not investment advice.